| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Chih-Sung Liang, Ting-Hung Hsie. Myoclonus as an indicator of infection in patients with schizophrenia treated with clozapine. Journal of psychiatry & neuroscience : JPN. vol 36. issue 1. 2011-04-21. PMID:21167107. |
myoclonus as an indicator of infection in patients with schizophrenia treated with clozapine. |
2011-04-21 |
2023-08-12 |
Not clear |
| Sanjeev Sockalingam, Chekkera Shammi, Valerie Powell, Lucy Barker, Gary Remingto. Determining rates of hepatitis C in a clozapine treated cohort. Schizophrenia research. vol 124. issue 1-3. 2011-04-19. PMID:20605572. |
to determine the prevalence rates of hepatitis c in patients with schizophrenia and schizoaffective disorder being treated with clozapine. |
2011-04-19 |
2023-08-12 |
Not clear |
| Clarissa Kripk. Clozapine vs. other atypical antipsychotics for schizophrenia. American family physician. vol 83. issue 3. 2011-03-29. PMID:21302867. |
clozapine vs. other atypical antipsychotics for schizophrenia. |
2011-03-29 |
2023-08-12 |
Not clear |
| Nuruz Zaman, Milind Karale, Mark Agiu. Secondary enuresis & body dysmorphic disorder in a caucasian male with catatonic schizophrenia: a case report. Psychiatria Danubina. vol 22 Suppl 1. 2011-03-18. PMID:21057404. |
we explore the mechanisms of incontinence in schizophrenia and those due to clozapine. |
2011-03-18 |
2023-08-12 |
Not clear |
| Nuruz Zaman, Milind Karale, Mark Agiu. Secondary enuresis & body dysmorphic disorder in a caucasian male with catatonic schizophrenia: a case report. Psychiatria Danubina. vol 22 Suppl 1. 2011-03-18. PMID:21057404. |
this case highlights the need to inquire about incontinence in patients with schizophrenia prior to prescribing clozapine. |
2011-03-18 |
2023-08-12 |
Not clear |
| F Hanisch, J Friedemann, F Pillman. Combined treatment with quetiapine and sertindole in therapy refractory insomnia after clozapine discontinuation. Journal of psychopharmacology (Oxford, England). vol 24. issue 11. 2011-02-28. PMID:19939868. |
insomnia associated with chronic schizophrenia and after clozapine discontinuation represents a common, but mostly not predominant, complaint and often does not respond sufficiently to classical hypnotics. |
2011-02-28 |
2023-08-12 |
Not clear |
| F Hanisch, J Friedemann, F Pillman. Combined treatment with quetiapine and sertindole in therapy refractory insomnia after clozapine discontinuation. Journal of psychopharmacology (Oxford, England). vol 24. issue 11. 2011-02-28. PMID:19939868. |
we report the case of a 46-year-old patient with schizophrenia who developed a rebound insomnia confirmed by polysomnography after discontinuation of long-term treatment with clozapine and changing to sertindole therapy. |
2011-02-28 |
2023-08-12 |
Not clear |
| F Hanisch, J Friedemann, F Pillman. Combined treatment with quetiapine and sertindole in therapy refractory insomnia after clozapine discontinuation. Journal of psychopharmacology (Oxford, England). vol 24. issue 11. 2011-02-28. PMID:19939868. |
in conclusion, the combination of sertindole and quetiapine might be a safe and effective combination in therapy-refractory insomnia after clozapine discontinuation in schizophrenia. |
2011-02-28 |
2023-08-12 |
Not clear |
| Gabriele Sani, Giorgio D Kotzalidis, Alessio Simonetti, Andrea Solfanelli, Iginia Mancinelli, Giusy Calabrò, Pietro De Rossi, Ottavia De Luca, Giovanna Gentile, Luana Lionetto, Giovanni Manfredi, Nicoletta Girardi, Elisa Ambrosi, Maurizio Simmaco, Roberto Tatarell. Development of asymptomatic pancreatitis with paradoxically high serum clozapine levels in a patient with schizophrenia and the CYP1A2*1F/1F genotype. Journal of clinical psychopharmacology. vol 30. issue 6. 2011-02-22. PMID:21057239. |
development of asymptomatic pancreatitis with paradoxically high serum clozapine levels in a patient with schizophrenia and the cyp1a2*1f/1f genotype. |
2011-02-22 |
2023-08-12 |
Not clear |
| A Kuwilsky, B Krumm, S Englisch, H Dressing, M Zin. Long-term efficacy and tolerability of clozapine combined with ziprasidone or risperidone. Pharmacopsychiatry. vol 43. issue 6. 2011-02-08. PMID:20589598. |
treatment resistance in schizophrenia often leads to add-on of atypical antipsychotics to clozapine. |
2011-02-08 |
2023-08-12 |
Not clear |
| Emilia Jesien-Lewandowicz, Michal Spych, Jacek Fijuth, Radzislaw Korde. Solitary brain metastasis of an occult and stable small-cell lung cancer in a schizophrenic patient: a 3-year control. Lung cancer (Amsterdam, Netherlands). vol 69. issue 2. 2011-02-02. PMID:20537425. |
the patient was suffering from schizophrenia and has been treated with clozapine for 17 years. |
2011-02-02 |
2023-08-12 |
Not clear |
| Muhammad R Baig, Erica Navaira, Michael A Escamilla, Henriette Raventos, Consuelo Walss-Bas. Clozapine treatment causes oxidation of proteins involved in energy metabolism in lymphoblastoid cells: a possible mechanism for antipsychotic-induced metabolic alterations. Journal of psychiatric practice. vol 16. issue 5. 2011-02-02. PMID:20859109. |
in this study, the same proteomic approach was used to identify specific proteins oxidized after clozapine treatment in lymphoblastoid cell lines from patients with schizophrenia and normal controls. |
2011-02-02 |
2023-08-12 |
Not clear |
| Ashvind N Singh, Johnny L Matson, B D Hill, Russell D Pella, Christopher L Cooper, Angela D Adkin. The use of clozapine among individuals with intellectual disability: a review. Research in developmental disabilities. vol 31. issue 6. 2011-01-24. PMID:20692809. |
clozapine has been approved in the united states since 1990 for refractory or treatment resistant schizophrenia in the general population. |
2011-01-24 |
2023-08-12 |
Not clear |
| D Cohe. [Clozapine screening: white bloodcell counts no longer sufficient]. Tijdschrift voor psychiatrie. vol 52. issue 11. 2011-01-13. PMID:21064021. |
clozapine is an effective antipsychotic drug for the treatment of therapy-resistant schizophrenia. |
2011-01-13 |
2023-08-12 |
Not clear |
| Monica M Marcus, Charlotte Wiker, Olivia Frånberg, Asa Konradsson-Geuken, Xavier Langlois, Kent Jardemark, Torgny H Svensso. Adjunctive alpha2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission. The international journal of neuropsychopharmacology. vol 13. issue 7. 2011-01-10. PMID:19835668. |
compared to both first- and second-generation antipsychotic drugs (apds), clozapine shows superior efficacy in treatment-resistant schizophrenia. |
2011-01-10 |
2023-08-12 |
rat |
| Monica M Marcus, Charlotte Wiker, Olivia Frånberg, Asa Konradsson-Geuken, Xavier Langlois, Kent Jardemark, Torgny H Svensso. Adjunctive alpha2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission. The international journal of neuropsychopharmacology. vol 13. issue 7. 2011-01-10. PMID:19835668. |
these data propose that the therapeutic effect of risperidone in schizophrenia can be enhanced and its eps liability reduced by adjunctive treatment with an alpha2-adrenoceptor antagonist, and generally support the notion that the potent alpha2-adrenoceptor antagonistic action of clozapine may be highly important for its unique efficacy in schizophrenia. |
2011-01-10 |
2023-08-12 |
rat |
| Isabel Krämer, Christine Rauber-Lüthy, Hugo Kupferschmidt, Stephan Krähenbühl, Alessandro Cesch. Minimal dose for severe poisoning and influencing factors in acute human clozapine intoxication: a 13-year retrospective study. Clinical neuropharmacology. vol 33. issue 5. 2011-01-06. PMID:20689404. |
clozapine is an atypical antipsychotic drug used in the treatment of resistant schizophrenia. |
2011-01-06 |
2023-08-12 |
human |
| T Ponto, N I Ismail, A B Abdul Majeed, N H Marmaya, Z A Zakari. A prospective study on the pattern of medication use for schizophrenia in the outpatient pharmacy department, Hospital Tengku Ampuan Rahimah, Selangor, Malaysia. Methods and findings in experimental and clinical pharmacology. vol 32. issue 6. 2010-12-16. PMID:20852752. |
nearly 32% of the schizophrenia patients were prescribed with atypical antipsychotics such as olanzapine (10.8%), risperidone (10.0%), quetiapine (7.6%) and clozapine (3.2%). |
2010-12-16 |
2023-08-12 |
Not clear |
| Claudia Asenjo Lobos, Katja Komossa, Christine Rummel-Kluge, Heike Hunger, Franziska Schmid, Sandra Schwarz, Stefan Leuch. Clozapine versus other atypical antipsychotics for schizophrenia. The Cochrane database of systematic reviews. issue 11. 2010-12-06. PMID:21069690. |
clozapine versus other atypical antipsychotics for schizophrenia. |
2010-12-06 |
2023-08-12 |
Not clear |
| Claudia Asenjo Lobos, Katja Komossa, Christine Rummel-Kluge, Heike Hunger, Franziska Schmid, Sandra Schwarz, Stefan Leuch. Clozapine versus other atypical antipsychotics for schizophrenia. The Cochrane database of systematic reviews. issue 11. 2010-12-06. PMID:21069690. |
clozapine is an atypical antipsychotic demonstrated to be superior in the treatment of refractory schizophrenia which causes fewer movement disorders. |
2010-12-06 |
2023-08-12 |
Not clear |